多机构临床工具预测3特斯拉多参数前列腺磁共振成像上的高风险病灶
研究基于四家三级中心回顾性和前瞻性数据,利用年龄、前列腺特异性抗原和前列腺体积构建支持向量机模型,预测活检初治、既往活检阴性及主动监测患者mpMRI上PI-RADS 4或5病灶的概率。模型在活检初治和既往活检阴性患者(n=811)内部验证AUC为0.730,在两个独立机构前瞻性外部验证(n=88和n=126)AUC分别为0.740和0.744。作者结论认为BiRCH模型可用于筛选活检初治或既往活检阴性患者接受mpMRI。
要点
- 基于年龄、PSA和前列腺体积的BiRCH模型可预测mpMRI上PI-RADS 4或5病灶。
- 活检初治和既往活检阴性患者内部验证AUC为0.730。
- 两个独立机构前瞻性外部验证AUC分别为0.740和0.744。
核心结论
- 在活检初治或既往活检阴性的患者中,BiRCH模型可用于筛选患者接受mpMRI。
研究设计与样本
- 四家三级中心参与的回顾性和前瞻性研究(BiRCH Study Collaborative)。
- 使用1269例接受mpMRI的活检初治、既往活检阴性和主动监测患者生成统计模型。
- 利用年龄、前列腺特异性抗原和前列腺体积开发支持向量机模型,预测携带PI-RADS 4或5病灶的概率。
- 在214例连续患者中前瞻性评估未来预测的准确性。
主要发现
- 活检初治和既往活检阴性患者(n=811)内部验证的AUC为0.730,校准良好且净临床获益高。
- 在两个独立机构前瞻性外部验证(n=88和n=126),机器学习模型区分度AUC分别为0.740和0.744。
- 最终模型在Microsoft Azure Machine Learning平台开发(birch.azurewebsites.net)。
- 该模型需要前列腺体积测量作为输入。
关键数值与推荐
- 预测目标为mpMRI上PI-RADS 4或5病灶的概率。
- 模型输入变量为年龄、前列腺特异性抗原和前列腺体积。
临床怎么用
- 作者结论认为,在活检初治或既往活检阴性患者中,BiRCH模型可用于筛选患者接受mpMRI。
- 作者指出该工具可帮助医疗专业人员和患者就是否接受MRI做出知情决定。
局限性
- 该模型需要前列腺体积测量作为输入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) for prostate cancer detection without careful patient selection may lead to excessive resource utilization and costs. OBJECTIVE: To develop and validate a clinical tool for predicting the presence of high-risk lesions on mpMRI. DESIGN, SETTING, AND PARTICIPANTS: Four tertiary care centers were included in this retrospective and prospective study (BiRCH Study Collaborative). Statistical models were generated using 1269 biopsy-naive, prior negative biopsy, and active surveillance patients who underwent mpMRI. Using age, prostate-specific antigen, and prostate volume, a support vector machine model was developed for predicting the probability of harboring Prostate Imaging Reporting and Data System 4 or 5 lesions. The accuracy of future predictions was then prospectively assessed in 214 consecutive patients. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Receiver operating characteristic, calibration, and decision curves were generated to assess model performance. RESULTS AND LIMITATIONS: For biopsy-naïve and prior negative biopsy patients (n=811), the area under the curve (AUC) was 0.730 on internal validation. Excellent calibration and high net clinical benefit were observed. On prospective external validation at two separate institutions (n=88 and n=126), the machine learning model discriminated with AUCs of 0.740 and 0.744, respectively. The final model was developed on the Microsoft Azure Machine Learning platform (birch.azurewebsites.net). This model requires a prostate volume measurement as input. CONCLUSIONS: In patients who are naïve to biopsy or those with a prior negative biopsy, BiRCH models can be used to select patients for mpMRI. PATIENT SUMMARY: In this multicenter study, we developed and prospectively validated a calculator that can be used to predict prostate magnetic resonance imaging (MRI) results using patient age, prostate-specific antigen, and prostate volume as input. This tool can aid health care professionals and patients to make an informed decision regarding whether to get an MRI.
引用
- Truong M, Baack Kukreja JE, Rais-Bahrami S, et al. Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging. Eur Urol Oncol. 2019. PMID: 31200839. doi:10.1016/j.euo.2018.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。